Achieve Life Sciences, Inc. Adjustment of Warrants Granted for Services
Achieve Life Sciences, Inc. (ACHV) reported Adjustment of Warrants Granted for Services of -$2.52 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2012-11-08
- Achieve Life Sciences, Inc. adjustment of warrants granted for services for the quarter ending 2012-09-30 was -$2.31M.
- Achieve Life Sciences, Inc. adjustment of warrants granted for services for the quarter ending 2012-06-30 was -$1.64M, a 197.39% decline year-over-year.
- Achieve Life Sciences, Inc. adjustment of warrants granted for services for the quarter ending 2012-03-31 was $1.43M.
- Achieve Life Sciences, Inc. adjustment of warrants granted for services for the quarter ending 2011-12-31 was $1.63M.
- Achieve Life Sciences, Inc. adjustment of warrants granted for services for fiscal 2011 was -$7.39M.
- Achieve Life Sciences, Inc. adjustment of warrants granted for services for fiscal 2010 was -$96.00K.
| Period end | Adjustment of Warrants Granted for Services 3 month | Adjustment of Warrants Granted for Services 6 month | Adjustment of Warrants Granted for Services 9 month | Adjustment of Warrants Granted for Services 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$3.95M derived: sum of 2 quarters · filed 2012-11-08 | -$2.52M 10-Q · filed 2012-11-08 | -$889.00K derived: sum of 4 quarters · filed 2012-11-08 |
| 2012-06-30 | -$1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$214.00K 10-Q · filed 2012-08-02 | $1.42M derived: sum of 3 quarters · filed 2012-08-02 | -$7.16M derived: sum of 4 quarters · filed 2012-11-08 |
| 2012-03-31 | $1.43M 10-Q · filed 2012-05-03 | $3.06M derived: sum of 2 quarters · filed 2012-05-03 | -$5.52M derived: sum of 3 quarters · filed 2012-11-08 | -$3.83M derived: sum of 4 quarters · filed 2012-11-08 |
| 2011-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | -$6.95M derived: sum of 2 quarters · filed 2012-11-08 | -$5.26M derived: sum of 3 quarters · filed 2012-11-08 | -$7.39M 10-K · filed 2012-03-08 |
| 2011-09-30 | -$8.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$6.89M derived: sum of 2 quarters · filed 2012-11-08 | -$9.02M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$440.00K 10-Q · filed 2012-08-02 | ||
| 2011-03-31 | -$2.13M 10-Q · filed 2012-05-03 | |||
| 2010-12-31 | -$96.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |